Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma

Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma

Background: This prospective phase II clinical trial evaluated the efficacy and toxicity of cisplatin, oral tegafur-uracil, leucovorin, and mitomycin C in patients with recurrent or metastatic nasopharyngeal carcinoma. Methods: Patients with histologically proven non-keratinizing or undifferentiate...

Full description

Bibliographic Details
Main Authors: Chia-Hsun Hsieh, Cheng-lung Hsu, Cheng-Hsu Wang, Chaung-Chi Liaw, Jen-Shi Chen, Hsien-Kun Chang, Tsai-Shen Yang, John Wen-Chen Chang, Yung-Chang Lin, Chi-Ting Liau, Ngan-Ming Tsang, Joseph Tung-Chieh Chang, Shu-Hang Ng, Hung-Ming Wang
Format: Article
Language:English
Published: Elsevier 2013-10-01
Series:Biomedical Journal
Subjects:
Cisplatin
head and neck neoplasms
leucovorin
mitomycin C
nasopharyngeal cancer
tegafur-uracil
Online Access:http://www.biomedj.org/article.asp?issn=2319-4170;year=2013;volume=36;issue=5;spage=229;epage=236;aulast=Hsieh

Internet

http://www.biomedj.org/article.asp?issn=2319-4170;year=2013;volume=36;issue=5;spage=229;epage=236;aulast=Hsieh

Similar Items